Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Gains from Investment Securities: 2017-2024

Historic Gains from Investment Securities for Cogent Biosciences (COGT) over the last 8 years, with Dec 2024 value amounting to $100,000.

  • Cogent Biosciences' Gains from Investment Securities fell 50.20% to $3.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was $3.7 million, marking a year-over-year decrease of 61.54%. This contributed to the annual value of $100,000 for FY2024, which is 83.33% down from last year.
  • Per Cogent Biosciences' latest filing, its Gains from Investment Securities stood at $100,000 for FY2024, which was down 83.33% from $600,000 recorded in FY2023.
  • In the past 5 years, Cogent Biosciences' Gains from Investment Securities ranged from a high of $25.2 million in FY2022 and a low of $100,000 during FY2021.
  • For the 3-year period, Cogent Biosciences' Gains from Investment Securities averaged around $8.6 million, with its median value being $600,000 (2023).
  • Per our database at Business Quant, Cogent Biosciences' Gains from Investment Securities tumbled by 98.67% in 2021 and then skyrocketed by 25,084.00% in 2022.
  • Over the past 5 years, Cogent Biosciences' Gains from Investment Securities (Yearly) stood at $7.5 million in 2020, then crashed by 98.67% to $100,000 in 2021, then surged by 25,084.00% to $25.2 million in 2022, then crashed by 97.62% to $600,000 in 2023, then slumped by 83.33% to $100,000 in 2024.